• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC CARTO VIZIGO¿ 8.5F BI-DIRECTIONAL GUIDING SHEATH - MEDIUM; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC CARTO VIZIGO¿ 8.5F BI-DIRECTIONAL GUIDING SHEATH - MEDIUM; INTRODUCER, CATHETER Back to Search Results
Model Number D138502
Device Problems Material Separation (1562); Obstruction of Flow (2423); Material Deformation (2976)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/28/2022
Event Type  malfunction  
Event Description
It was reported that a patient underwent an atrial fibrillation (afib) ablation procedure with a carto vizigo¿ 8.5f bi-directional guiding sheath - medium and a hemostatic valve separation issue occurred.It was reported that the vizigo¿ sheath dilator would not fit into the sheath.There was resistance when trying to put the dilator into the sheath.There was no damage upon opening but from trying to insert the dilator, the valve of the sheath was damaged, and kinks were in the dilator.When trying to flush the sheath, the irrigation back flowed out of the valve.There didn¿t appear to be anything inside the sheath occluding the dilator.It was unable to be advanced into the sheath.The sheath was replaced, and the issue resolved.No adverse patient consequence was reported.The obstructed ¿ sheath and dilator damage issues were assessed as not mdr reportable.The hemostatic valve separation was assessed as a mdr reportable product malfunction.
 
Manufacturer Narrative
The biosense webster, inc.Product analysis lab received the device for evaluation.The analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Manufacturer Narrative
The device evaluation was completed on 28-mar-2022.It was reported that a patient underwent an atrial fibrillation (afib) ablation procedure with a carto vizigo¿ 8.5f bi-directional guiding sheath ¿ medium (stsf) and a hemostatic valve separation issue occurred.It was reported that the vizigo¿ sheath dilator would not fit into the sheath.There was resistance when trying to put the dilator into the sheath.There was no damage upon opening but from trying to insert the dilator, the valve of the sheath was damaged, and kinks were in the dilator.When trying to flush the sheath, the irrigation back flowed out of the valve.There didn¿t appear to be anything inside the sheath occluding the dilator.It was unable to be advanced into the sheath.The sheath was replaced, and the issue resolved.No adverse patient consequence was reported.Device evaluation details: visual analysis revealed that the hemostatic valve was found dislodged inside the vizigo¿ sheath hub.Microscopic examination in the hemostatic valve surface showed evidence of stress marks on the outer diameter.On the other hand, the brim cap and the silicone ring were placed in the correct position and found in good conditions.Also, the dilator and an stsf catheter were introduced into the vizigo¿ sheath (with no brim cap), and resistance was detected.The outer diameter of the dilator was measured, and it was within specifications.It should be noted that product failure is multifactorial.It was determined that the issue observed could be related to the incorrect insertion of the dilator into the sheath, causing the dislodgment of the valve.The stress marks and the physical damage observed in the dilator suggest that excessive force was applied, which is related to the resistance detected by the customer when it was tried to insert the dilator into the sheath.A device history record (dhr) evaluation was performed for the finished device [50000063] number, and no internal actions related to the reported complaint condition were identified.Based on the dhr, the h4.Device manufacture date has been updated.According to the odp (optimal performance guide), there are some precautions and recommendations on inserting the dilator into the vizigo¿ sheath: -always insert a dilator straight into the center of the sheath's valve to prevent damage to the valve.Do not insert a dilator at an angle, as damage to the sheath valve may occur.-if resistance is encountered, do not use excessive force to advance or withdraw the catheter through the sheath.As part of the quality process, all devices are manufactured, inspected, and released to approved specifications.This issue will be addressed through bwi's quality system.Explanation of codes: investigation findings: material and/or chemical problem identified (c06) / investigation conclusions: cause not established (d15) / component code: device ingredient or reagent (g01003) were selected as related to the obstructed sheath issue.Investigation findings: fracture problem (c070603) / investigation conclusions: cause not established (d15)/ component code: valve(s) (g04135) were selected as related to the hemostatic valve separation issue.Investigation findings: no device problem found (c19) / investigation conclusions: no problem detected (d14) were selected as related to the dilator damage.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARTO VIZIGO¿ 8.5F BI-DIRECTIONAL GUIDING SHEATH - MEDIUM
Type of Device
INTRODUCER, CATHETER
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (IRVINE)
33 technology drive
irvine CA 92618
Manufacturer Contact
gabriel alfageme
31 technology dr
irvine, CA 92618
9497898687
MDR Report Key13592406
MDR Text Key289887236
Report Number2029046-2022-00372
Device Sequence Number1
Product Code DYB
UDI-Device Identifier10846835016277
UDI-Public10846835016277
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K170997
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 04/25/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/01/2022
Device Model NumberD138502
Device Catalogue NumberD138502
Device Lot Number50000063
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/18/2022
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 01/28/2022
Initial Date FDA Received02/24/2022
Supplement Dates Manufacturer Received03/28/2022
Supplement Dates FDA Received04/25/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/01/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
UNK BRAND SHEATH.
-
-